Kenosha, WI, United States of America

Robert K Engh


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2002-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Robert K Engh in Controlled Release Formulations

Introduction

Robert K Engh is an accomplished inventor based in Kenosha, Wisconsin, known for his significant contributions to the field of pharmaceutical formulations. He holds two patents that focus on controlled release formulations of divalproex sodium, a medication used in the treatment of epilepsy. His work has paved the way for advancements in medication delivery systems, enhancing patient compliance and treatment efficacy.

Latest Patents

Engh's latest patents include a controlled release tablet formulation that allows for once-daily dosing in the treatment of epilepsy. This formulation comprises approximately 50 to 55 weight percent of an active ingredient selected from valproic acid, divalproex sodium, and other related compounds. Additionally, it contains hydroxypropyl methylcellulose, lactose, microcrystalline cellulose, and silicon dioxide, all contributing to the tablet's effectiveness. The patents also disclose methods for manufacturing these formulations and their application in treating epilepsy.

Career Highlights

Engh has made significant strides in his career, particularly through his work at Abbott Laboratories Corporation. His innovative approach to pharmaceutical formulations has led to the development of effective treatment options for patients suffering from epilepsy. His expertise in controlled release technology has been instrumental in improving medication adherence and therapeutic outcomes.

Collaborations

Engh has collaborated with notable colleagues, including Yihong Qiu and Paul Richard Poska. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the quality of their research and development efforts.

Conclusion

Robert K Engh's contributions to controlled release formulations have made a significant impact in the pharmaceutical industry. His work continues to influence the development of effective treatments for epilepsy, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…